top of page
Abstract Structure

Transaction and News

Collabrium Partners Advises Chinese E-commerce Group on its Strategic Partnership with Italian Cosmetics Brand Harbor S.p.A.

March 3, 2023 at 3:57:17 PM

Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901

February 24, 2023 at 1:18:28 AM

MingZhu Logistics to Acquire Alliance Liquor

February 22, 2023 at 2:13:47 AM

Hengrui Licenses EZH2 Inhibitor to Treeline in $700M Deal

February 15, 2023 at 12:32:07 AM

HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China

January 23, 2023 at 1:11:25 PM

Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

December 27, 2022 at 1:44:59 PM

Abstract Structure
logo_blue & gold.png

Company

Business

Legal

Location

Collabrium Partners & Co. Limited

9/F, Surson Commercial Building
140-142 Austin Road,
Tsim Sha Tsui, Kowloon,
Hong Kong

© 2019 Collabrium Partners & Co. Limited all rights reserved.

Mergers & Acquisitions
Strategic Advisory
Capital Restructuring
Private Placement
Special Committee
Independent Advice
Privacy Policy
Other Notices
Hong Kong
Beijing
Shanghai
Shenzhen
New York
London
Dubai
bottom of page